adalimumab,ustekinumab
janssen,abbvie
['serene', 'stardust']
 conclusions from stardust and serene (and other ttt studies): when the drug works, it will usually work at standard dose. if standard dose doesn't work, if won't work no matter how much you give. this is why we did phase 2 studies in the first place
Swedish physician specializing in the treatment of Crohn's disease and Ulcerative Colitis. Views - my own.